<?xml version="1.0" encoding="UTF-8"?>
<ClinicalDocument xmlns="urn:hl7-org:v3" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
  <realmCode code="US"/>
  <typeId root="2.16.840.1.113883.1.3" extension="POCD_HD000040"/>
  <templateId root="2.16.840.1.113883.10.20.22.1.1" extension="2015-08-01"/>
  <templateId root="2.16.840.1.113883.10.20.22.1.9" extension="2015-08-01"/>
  <id root="c6c90d95-a3c3-4ab8-ac98-8c1c606e7868"/>
  <code code="11506-3" codeSystem="2.16.840.1.113883.6.1" codeSystemName="LOINC" displayName="Progress note"/>
  <title>SYNTHETIC RECORD, NOT A REAL MEDICAL RECORD — Progress Note 3 — Focused Visit (Follow-up) — Ida B. Wells — True-date frame: synthetic events are moved into the patient&apos;s historical lifetime. Codes, instruments, and treatments remain modern and are anachronistic.</title>
  <effectiveTime value="19310203120000-0500"/>
  <confidentialityCode code="N" codeSystem="2.16.840.1.113883.5.25"/>
  <languageCode code="en-US"/>
  <setId root="2255fd6e-4c6e-4696-a9e6-f0903683c7f5"/>
  <versionNumber value="1"/>
  <recordTarget>
    <patientRole>
      <id root="6a0803fd-8956-4ef4-997c-7b033779efa7" extension="HR-ET022-SYN-TD"/>
      <id root="2.16.840.1.113883.4.1" extension="000-22-5903"/>
      <addr nullFlavor="UNK"/>
      <telecom nullFlavor="UNK"/>
      <patient>
        <name use="L"><given>Ida</given><given>B.</given><family>Wells</family></name>
        <administrativeGenderCode code="F" codeSystem="2.16.840.1.113883.5.1" displayName="Female"/>
        <birthTime value="18620716"/>
        <raceCode nullFlavor="ASKU"/>
        <ethnicGroupCode nullFlavor="ASKU"/>
        <languageCommunication><languageCode code="en"/><preferenceInd value="true"/></languageCommunication>
      </patient>
      <providerOrganization>
        <id root="6a7f851b-842b-45d7-9552-3e8582647414"/>
        <name>St. Posthumous Health Center</name>
      <telecom use="WP" value="tel:+1-202-555-0100"/>
      <addr use="WP"><streetAddressLine>100 Forge Way</streetAddressLine><city>Aetherton</city><state>OR</state><postalCode>00000</postalCode><country>US</country></addr>
      </providerOrganization>
    </patientRole>
  </recordTarget>
  <author>
    <time value="19310203120000-0500"/>
    <assignedAuthor><id root="59af261c-e362-4af2-96f3-d521c3a3b0f9"/><addr nullFlavor="UNK"/><telecom nullFlavor="UNK"/><assignedPerson><name><given>Cordelia</given><family>Ashworth-Banks</family><suffix>MD</suffix></name></assignedPerson><representedOrganization><id root="6a7f851b-842b-45d7-9552-3e8582647414"/><name>St. Posthumous Health Center</name><telecom use="WP" value="tel:+1-202-555-0100"/>
      <addr use="WP"><streetAddressLine>100 Forge Way</streetAddressLine><city>Aetherton</city><state>OR</state><postalCode>00000</postalCode><country>US</country></addr></representedOrganization></assignedAuthor>
  </author>
  <custodian>
    <assignedCustodian><representedCustodianOrganization><id root="6a7f851b-842b-45d7-9552-3e8582647414"/><name>St. Posthumous Health Center</name><telecom use="WP" value="tel:+1-202-555-0100"/>
      <addr use="WP"><streetAddressLine>100 Forge Way</streetAddressLine><city>Aetherton</city><state>OR</state><postalCode>00000</postalCode><country>US</country></addr></representedCustodianOrganization></assignedCustodian>
  </custodian>
  <legalAuthenticator>
    <time value="19310203120000-0500"/>
    <signatureCode code="S"/>
    <assignedEntity><id root="59af261c-e362-4af2-96f3-d521c3a3b0f9"/><addr nullFlavor="UNK"/><telecom nullFlavor="UNK"/><assignedPerson><name><given>Cordelia</given><family>Ashworth-Banks</family><suffix>MD</suffix></name></assignedPerson><representedOrganization><id root="6a7f851b-842b-45d7-9552-3e8582647414"/><name>St. Posthumous Health Center</name><telecom use="WP" value="tel:+1-202-555-0100"/>
      <addr use="WP"><streetAddressLine>100 Forge Way</streetAddressLine><city>Aetherton</city><state>OR</state><postalCode>00000</postalCode><country>US</country></addr></representedOrganization></assignedEntity>
  </legalAuthenticator>
  <documentationOf>
    <serviceEvent classCode="PCPR"><templateId root="2.16.840.1.113883.10.20.21.3.1"/><effectiveTime><low value="19310203"/><high value="19310203"/></effectiveTime><performer typeCode="PRF"><assignedEntity><id root="59af261c-e362-4af2-96f3-d521c3a3b0f9"/><addr nullFlavor="UNK"/><telecom nullFlavor="UNK"/><assignedPerson><name><given>Cordelia</given><family>Ashworth-Banks</family><suffix>MD</suffix></name></assignedPerson><representedOrganization><id root="6a7f851b-842b-45d7-9552-3e8582647414"/><name>St. Posthumous Health Center</name><telecom use="WP" value="tel:+1-202-555-0100"/>
      <addr use="WP"><streetAddressLine>100 Forge Way</streetAddressLine><city>Aetherton</city><state>OR</state><postalCode>00000</postalCode><country>US</country></addr></representedOrganization></assignedEntity></performer></serviceEvent>
  </documentationOf>
  <componentOf>
    <encompassingEncounter>
      <id root="72ed0cfa-61db-4f26-8e17-30a59f67f668"/>
      <code code="390906007" codeSystem="2.16.840.1.113883.6.96" displayName="Follow-up encounter"><originalText>Two weeks after starting losartan: potassium, creatinine and blood pressure, and the decision about dapagliflozin</originalText></code>
      <effectiveTime><low value="19310203"/><high value="19310203"/></effectiveTime>
      <encounterParticipant typeCode="ATND"><assignedEntity><id root="59af261c-e362-4af2-96f3-d521c3a3b0f9"/><addr nullFlavor="UNK"/><telecom nullFlavor="UNK"/><assignedPerson><name><given>Cordelia</given><family>Ashworth-Banks</family><suffix>MD</suffix></name></assignedPerson><representedOrganization><id root="6a7f851b-842b-45d7-9552-3e8582647414"/><name>St. Posthumous Health Center</name><telecom use="WP" value="tel:+1-202-555-0100"/>
      <addr use="WP"><streetAddressLine>100 Forge Way</streetAddressLine><city>Aetherton</city><state>OR</state><postalCode>00000</postalCode><country>US</country></addr></representedOrganization></assignedEntity></encounterParticipant>
      <location><healthCareFacility><id root="6a7f851b-842b-45d7-9552-3e8582647414"/><serviceProviderOrganization><id root="6a7f851b-842b-45d7-9552-3e8582647414"/><name>St. Posthumous Health Center</name><telecom use="WP" value="tel:+1-202-555-0100"/>
      <addr use="WP"><streetAddressLine>100 Forge Way</streetAddressLine><city>Aetherton</city><state>OR</state><postalCode>00000</postalCode><country>US</country></addr></serviceProviderOrganization></healthCareFacility></location>
    </encompassingEncounter>
  </componentOf>
  <component>
    <structuredBody>

<component>
  <section>
    <templateId root="1.3.6.1.4.1.19376.1.5.3.1.1.13.2.1"/>
    <code code="10154-3" codeSystem="2.16.840.1.113883.6.1" displayName="Chief complaint Narrative - Reported"/>
    <title>Chief Complaint</title>
    <text><paragraph>Two weeks after starting losartan: potassium, creatinine and blood pressure, and the decision about dapagliflozin. [S]</paragraph></text>

  </section>
</component>

<component>
  <section>
    <templateId root="1.3.6.1.4.1.19376.1.5.3.1.3.4"/>
    <code code="10164-2" codeSystem="2.16.840.1.113883.6.1" displayName="History of Present illness Narrative"/>
    <title>History of Present Illness</title>
    <text><paragraph>Mrs. Wells returns two weeks after starting losartan 50 mg, atorvastatin and vitamin D3. She has had no dizziness, cough or swelling of the lips. Her home readings average 140/84. Her ankles swell less. She met the dietitian this morning and is cutting salt, and she has read about SGLT2 inhibitors and asked how much they lower the risk of kidney failure; the trial evidence in people with and without diabetes was explained. She wants to start. [S]</paragraph><table><thead><tr><th>Element</th><th>Detail</th></tr></thead><tbody><tr><td>Home blood pressure</td><td>Average 140/84</td></tr><tr><td>Side effects</td><td>None</td></tr><tr><td>Diet</td><td>Dietitian session this morning</td></tr></tbody></table></text>

  </section>
</component>

<component>
  <section>
    <templateId root="1.3.6.1.4.1.19376.1.5.3.1.3.18"/>
    <code code="10187-3" codeSystem="2.16.840.1.113883.6.1" displayName="Review of systems Narrative - Reported"/>
    <title>Review of Systems</title>
    <text><table><thead><tr><th>System</th><th>Result</th><th>Finding</th></tr></thead><tbody><tr><td>Constitutional</td><td>Positive</td><td>Still tired in the afternoons, a little less</td></tr><tr><td>Cardiovascular</td><td>Negative</td><td>Less ankle swelling; no chest pain</td></tr><tr><td>Neurological</td><td>Negative</td><td>No dizziness on standing</td></tr><tr><td>Genitourinary</td><td>Negative</td><td>No burning or genital itching</td></tr></tbody></table><paragraph>4 systems reviewed. [S]</paragraph></text>

  </section>
</component>

<component>
  <section>
    <templateId root="2.16.840.1.113883.10.20.22.2.1" extension="2014-06-09"/><templateId root="2.16.840.1.113883.10.20.22.2.1.1" extension="2014-06-09"/>
    <code code="10160-0" codeSystem="2.16.840.1.113883.6.1" displayName="History of Medication use Narrative"/>
    <title>Medications</title>
    <text><table><thead><tr><th>Medication</th><th>Frequency</th><th>Route</th><th>Dates</th><th>Status</th><th>Evidence</th></tr></thead><tbody><tr ID="medication-1"><td>Acetaminophen 500 mg oral tablet, one or two tablets up to three times a day as needed for knee aching (no more than 3,000 mg a day), in place of naproxen</td><td>One or two tablets up to three times a day as needed</td><td>Oral route</td><td>1931-01-05</td><td>active</td><td>S</td></tr><tr ID="medication-2"><td>Losartan 50 mg oral tablet, one tablet daily; hold on days of vomiting, diarrhea or not eating</td><td>One tablet daily, with sick-day rules</td><td>Oral route</td><td>1931-01-20 to 1931-03-03</td><td>completed</td><td>S</td></tr><tr ID="medication-3"><td>Atorvastatin 20 mg oral tablet, one tablet daily</td><td>One tablet daily</td><td>Oral route</td><td>1931-01-20</td><td>active</td><td>S</td></tr><tr ID="medication-4"><td>Cholecalciferol (vitamin D3) 25 mcg (1,000 units) oral tablet, one tablet daily</td><td>One tablet daily</td><td>Oral route</td><td>1931-01-20</td><td>active</td><td>S</td></tr><tr ID="medication-5"><td>Dapagliflozin 10 mg oral tablet, one tablet daily; hold on days of vomiting, diarrhea or not eating, and before surgery</td><td>One tablet daily, with sick-day rules</td><td>Oral route</td><td>1931-02-03</td><td>active</td><td>S</td></tr></tbody></table></text>

  <entry typeCode="DRIV">
    <substanceAdministration classCode="SBADM" moodCode="EVN">
      <templateId root="2.16.840.1.113883.10.20.22.4.16" extension="2014-06-09"/>
      <id root="ccbe88cb-fc58-4599-ab22-988297ba5ebc"/>
      <text><reference value="#medication-1"/></text>
      <statusCode code="active"/>
      <effectiveTime xsi:type="IVL_TS"><low value="19310105"/></effectiveTime>
      <effectiveTime xsi:type="PIVL_TS" institutionSpecified="false" operator="A"><period value="8" unit="h"/></effectiveTime>
      <routeCode code="C38288" codeSystem="2.16.840.1.113883.3.26.1.1" codeSystemName="NCI Thesaurus" displayName="Oral route"/>
      <doseQuantity value="1"/>
      <consumable>
        <manufacturedProduct classCode="MANU">
          <templateId root="2.16.840.1.113883.10.20.22.4.23" extension="2014-06-09"/>
          <manufacturedMaterial><code code="198440" codeSystem="2.16.840.1.113883.6.88" displayName="acetaminophen 500 MG Oral Tablet"/></manufacturedMaterial>
        </manufacturedProduct>
      </consumable>
      <entryRelationship typeCode="RSON">
        <observation classCode="OBS" moodCode="EVN">
          <templateId root="2.16.840.1.113883.10.20.22.4.19" extension="2014-06-09"/>
          <id root="6526a64c-3f94-4e48-b25b-a4b71deef7b2"/>
          <code code="55607006" codeSystem="2.16.840.1.113883.6.96" displayName="Problem"/>
          <statusCode code="completed"/>
          <value xsi:type="CD" code="N18.32" codeSystem="2.16.840.1.113883.6.90" displayName="Chronic kidney disease, stage 3b"/>
        </observation>
      </entryRelationship>
    </substanceAdministration>
  </entry>
  <entry typeCode="DRIV">
    <substanceAdministration classCode="SBADM" moodCode="EVN">
      <templateId root="2.16.840.1.113883.10.20.22.4.16" extension="2014-06-09"/>
      <id root="0a76f84d-8822-4178-a2b1-9eca1b5162db"/>
      <text><reference value="#medication-2"/></text>
      <statusCode code="completed"/>
      <effectiveTime xsi:type="IVL_TS"><low value="19310120"/><high value="19310303"/></effectiveTime>
      <effectiveTime xsi:type="PIVL_TS" institutionSpecified="false" operator="A"><period value="1" unit="d"/></effectiveTime>
      <routeCode code="C38288" codeSystem="2.16.840.1.113883.3.26.1.1" codeSystemName="NCI Thesaurus" displayName="Oral route"/>
      <doseQuantity value="1"/>
      <consumable>
        <manufacturedProduct classCode="MANU">
          <templateId root="2.16.840.1.113883.10.20.22.4.23" extension="2014-06-09"/>
          <manufacturedMaterial><code code="979492" codeSystem="2.16.840.1.113883.6.88" displayName="losartan potassium 50 MG Oral Tablet"/></manufacturedMaterial>
        </manufacturedProduct>
      </consumable>
      <entryRelationship typeCode="RSON">
        <observation classCode="OBS" moodCode="EVN">
          <templateId root="2.16.840.1.113883.10.20.22.4.19" extension="2014-06-09"/>
          <id root="5324d8bd-ca21-423f-a3cb-7a3b42fc4739"/>
          <code code="55607006" codeSystem="2.16.840.1.113883.6.96" displayName="Problem"/>
          <statusCode code="completed"/>
          <value xsi:type="CD" code="I12.9" codeSystem="2.16.840.1.113883.6.90" displayName="Hypertensive chronic kidney disease with stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease"/>
        </observation>
      </entryRelationship>
      <entryRelationship typeCode="RSON">
        <observation classCode="OBS" moodCode="EVN">
          <templateId root="2.16.840.1.113883.10.20.22.4.19" extension="2014-06-09"/>
          <id root="4688739a-a861-4aff-a573-f3d13a358674"/>
          <code code="55607006" codeSystem="2.16.840.1.113883.6.96" displayName="Problem"/>
          <statusCode code="completed"/>
          <value xsi:type="CD" code="N18.32" codeSystem="2.16.840.1.113883.6.90" displayName="Chronic kidney disease, stage 3b"/>
        </observation>
      </entryRelationship>
    </substanceAdministration>
  </entry>
  <entry typeCode="DRIV">
    <substanceAdministration classCode="SBADM" moodCode="EVN">
      <templateId root="2.16.840.1.113883.10.20.22.4.16" extension="2014-06-09"/>
      <id root="8553255b-27fe-4ca0-aad8-51160cd697f4"/>
      <text><reference value="#medication-3"/></text>
      <statusCode code="active"/>
      <effectiveTime xsi:type="IVL_TS"><low value="19310120"/></effectiveTime>
      <effectiveTime xsi:type="PIVL_TS" institutionSpecified="false" operator="A"><period value="1" unit="d"/></effectiveTime>
      <routeCode code="C38288" codeSystem="2.16.840.1.113883.3.26.1.1" codeSystemName="NCI Thesaurus" displayName="Oral route"/>
      <doseQuantity value="1"/>
      <consumable>
        <manufacturedProduct classCode="MANU">
          <templateId root="2.16.840.1.113883.10.20.22.4.23" extension="2014-06-09"/>
          <manufacturedMaterial><code code="617310" codeSystem="2.16.840.1.113883.6.88" displayName="atorvastatin 20 MG Oral Tablet"/></manufacturedMaterial>
        </manufacturedProduct>
      </consumable>
      <entryRelationship typeCode="RSON">
        <observation classCode="OBS" moodCode="EVN">
          <templateId root="2.16.840.1.113883.10.20.22.4.19" extension="2014-06-09"/>
          <id root="616d639d-3ae7-4453-bb2b-6bfce1ef18a4"/>
          <code code="55607006" codeSystem="2.16.840.1.113883.6.96" displayName="Problem"/>
          <statusCode code="completed"/>
          <value xsi:type="CD" code="N18.32" codeSystem="2.16.840.1.113883.6.90" displayName="Chronic kidney disease, stage 3b"/>
        </observation>
      </entryRelationship>
    </substanceAdministration>
  </entry>
  <entry typeCode="DRIV">
    <substanceAdministration classCode="SBADM" moodCode="EVN">
      <templateId root="2.16.840.1.113883.10.20.22.4.16" extension="2014-06-09"/>
      <id root="398be743-be8d-4f95-bc77-3627e5e22656"/>
      <text><reference value="#medication-4"/></text>
      <statusCode code="active"/>
      <effectiveTime xsi:type="IVL_TS"><low value="19310120"/></effectiveTime>
      <effectiveTime xsi:type="PIVL_TS" institutionSpecified="false" operator="A"><period value="1" unit="d"/></effectiveTime>
      <routeCode code="C38288" codeSystem="2.16.840.1.113883.3.26.1.1" codeSystemName="NCI Thesaurus" displayName="Oral route"/>
      <doseQuantity value="1"/>
      <consumable>
        <manufacturedProduct classCode="MANU">
          <templateId root="2.16.840.1.113883.10.20.22.4.23" extension="2014-06-09"/>
          <manufacturedMaterial><code code="199362" codeSystem="2.16.840.1.113883.6.88" displayName="cholecalciferol 0.025 MG Oral Tablet"/></manufacturedMaterial>
        </manufacturedProduct>
      </consumable>
      <entryRelationship typeCode="RSON">
        <observation classCode="OBS" moodCode="EVN">
          <templateId root="2.16.840.1.113883.10.20.22.4.19" extension="2014-06-09"/>
          <id root="6d4fa099-7de1-4ba6-851a-cc29a1c04047"/>
          <code code="55607006" codeSystem="2.16.840.1.113883.6.96" displayName="Problem"/>
          <statusCode code="completed"/>
          <value xsi:type="CD" code="E55.9" codeSystem="2.16.840.1.113883.6.90" displayName="Vitamin D deficiency, unspecified"/>
        </observation>
      </entryRelationship>
    </substanceAdministration>
  </entry>
  <entry typeCode="DRIV">
    <substanceAdministration classCode="SBADM" moodCode="EVN">
      <templateId root="2.16.840.1.113883.10.20.22.4.16" extension="2014-06-09"/>
      <id root="4b173763-0285-428f-968a-a7ec7d3a1ba7"/>
      <text><reference value="#medication-5"/></text>
      <statusCode code="active"/>
      <effectiveTime xsi:type="IVL_TS"><low value="19310203"/></effectiveTime>
      <effectiveTime xsi:type="PIVL_TS" institutionSpecified="false" operator="A"><period value="1" unit="d"/></effectiveTime>
      <routeCode code="C38288" codeSystem="2.16.840.1.113883.3.26.1.1" codeSystemName="NCI Thesaurus" displayName="Oral route"/>
      <doseQuantity value="1"/>
      <consumable>
        <manufacturedProduct classCode="MANU">
          <templateId root="2.16.840.1.113883.10.20.22.4.23" extension="2014-06-09"/>
          <manufacturedMaterial><code code="1488569" codeSystem="2.16.840.1.113883.6.88" displayName="dapagliflozin 10 MG Oral Tablet"/></manufacturedMaterial>
        </manufacturedProduct>
      </consumable>
      <entryRelationship typeCode="RSON">
        <observation classCode="OBS" moodCode="EVN">
          <templateId root="2.16.840.1.113883.10.20.22.4.19" extension="2014-06-09"/>
          <id root="c205aee2-3279-48c7-b3b4-6f9eb1c86222"/>
          <code code="55607006" codeSystem="2.16.840.1.113883.6.96" displayName="Problem"/>
          <statusCode code="completed"/>
          <value xsi:type="CD" code="N18.32" codeSystem="2.16.840.1.113883.6.90" displayName="Chronic kidney disease, stage 3b"/>
        </observation>
      </entryRelationship>
    </substanceAdministration>
  </entry>
  </section>
</component>

<component>
  <section>
    <templateId root="2.16.840.1.113883.10.20.22.2.6" extension="2015-08-01"/><templateId root="2.16.840.1.113883.10.20.22.2.6.1" extension="2015-08-01"/>
    <code code="48765-2" codeSystem="2.16.840.1.113883.6.1" displayName="Allergies and adverse reactions Document"/>
    <title>Allergies and Intolerances</title>
    <text><table><thead><tr><th>Allergy</th><th>Reaction</th><th>Status</th><th>Evidence</th></tr></thead><tbody><tr ID="allergy-1"><td>No known allergy</td><td></td><td>active</td><td>S</td></tr></tbody></table></text>

  <entry typeCode="DRIV">
    <act classCode="ACT" moodCode="EVN">
      <templateId root="2.16.840.1.113883.10.20.22.4.30" extension="2015-08-01"/>
      <id root="edb34ff8-106d-4654-88e7-b89b9326a6ff"/>
      <code code="CONC" codeSystem="2.16.840.1.113883.5.6" displayName="Concern"/>
      <statusCode code="active"/>
      <effectiveTime><low value="19310105"/></effectiveTime>
      <entryRelationship typeCode="SUBJ">
        <observation classCode="OBS" moodCode="EVN" negationInd="true">
          <templateId root="2.16.840.1.113883.10.20.22.4.7" extension="2014-06-09"/>
          <id root="4d91d1e8-c5ac-4e84-8f40-217a61926ef9"/>
          <code code="ASSERTION" codeSystem="2.16.840.1.113883.5.4"/>
          <text><reference value="#allergy-1"/></text>
          <statusCode code="completed"/>
          <effectiveTime><low nullFlavor="UNK"/></effectiveTime>
          <value xsi:type="CD" code="419199007" codeSystem="2.16.840.1.113883.6.96" displayName="Allergy to substance"/>
          <participant typeCode="CSM"><participantRole classCode="MANU"><playingEntity classCode="MMAT"><code nullFlavor="NA"/></playingEntity></participantRole></participant>
        </observation>
      </entryRelationship>
    </act>
  </entry>
  </section>
</component>

<component>
  <section>
    <templateId root="2.16.840.1.113883.10.20.22.2.4" extension="2015-08-01"/><templateId root="2.16.840.1.113883.10.20.22.2.4.1" extension="2015-08-01"/>
    <code code="8716-3" codeSystem="2.16.840.1.113883.6.1" displayName="Vital signs"/>
    <title>Vital Signs</title>
    <text><table><thead><tr><th>Date</th><th>Measure</th><th>Value</th><th>Unit</th><th>Provenance</th></tr></thead><tbody>
  <tr ID="vital-3-1"><td>1931-02-03</td><td>Body height</td><td>157</td><td>cm</td><td>S</td></tr>
  <tr ID="vital-3-2"><td>1931-02-03</td><td>Body weight</td><td>69.6</td><td>kg</td><td>S</td></tr>
  <tr ID="vital-3-3"><td>1931-02-03</td><td>Body mass index (BMI) [Ratio]</td><td>28.2</td><td>kg/m2</td><td>S</td></tr>
  <tr ID="vital-3-4"><td>1931-02-03</td><td>Systolic blood pressure</td><td>142</td><td>mm[Hg]</td><td>S</td></tr>
  <tr ID="vital-3-5"><td>1931-02-03</td><td>Diastolic blood pressure</td><td>84</td><td>mm[Hg]</td><td>S</td></tr>
  <tr ID="vital-3-6"><td>1931-02-03</td><td>Heart rate</td><td>74</td><td>/min</td><td>S</td></tr>
  <tr ID="vital-3-7"><td>1931-02-03</td><td>Respiratory rate</td><td>16</td><td>/min</td><td>S</td></tr>
  <tr ID="vital-3-8"><td>1931-02-03</td><td>Body temperature</td><td>36.6</td><td>Cel</td><td>S</td></tr>
  <tr ID="vital-3-9"><td>1931-02-03</td><td>Oxygen saturation in Arterial blood by Pulse oximetry</td><td>97</td><td>%</td><td>S</td></tr></tbody></table></text>

  <entry typeCode="DRIV">
    <organizer classCode="CLUSTER" moodCode="EVN">
      <templateId root="2.16.840.1.113883.10.20.22.4.26" extension="2015-08-01"/>
      <id root="f08c4cfd-a70e-47f4-9b99-5830773fea29"/>
      <code code="74728-7" codeSystem="2.16.840.1.113883.6.1" displayName="Vital signs, weight, height, head circumference, oximetry, BMI, and BSA panel - HL7.FHIR.R4"/>
      <statusCode code="completed"/><effectiveTime value="19310203"/>
      <component><observation classCode="OBS" moodCode="EVN"><templateId root="2.16.840.1.113883.10.20.22.4.27" extension="2014-06-09"/><id root="56e995b6-10ba-4b96-8e3e-c615beced62d"/><code code="8302-2" codeSystem="2.16.840.1.113883.6.1" displayName="Body height"/><text><reference value="#vital-3-1"/></text><statusCode code="completed"/><effectiveTime value="19310203"/><value xsi:type="PQ" value="157" unit="cm"/></observation></component><component><observation classCode="OBS" moodCode="EVN"><templateId root="2.16.840.1.113883.10.20.22.4.27" extension="2014-06-09"/><id root="0ce55d89-4aa9-45d2-b219-6b0e65b449a1"/><code code="29463-7" codeSystem="2.16.840.1.113883.6.1" displayName="Body weight"/><text><reference value="#vital-3-2"/></text><statusCode code="completed"/><effectiveTime value="19310203"/><value xsi:type="PQ" value="69.6" unit="kg"/></observation></component><component><observation classCode="OBS" moodCode="EVN"><templateId root="2.16.840.1.113883.10.20.22.4.27" extension="2014-06-09"/><id root="bbfe36a5-27b0-4d4b-8e29-9101f4eee4e2"/><code code="39156-5" codeSystem="2.16.840.1.113883.6.1" displayName="Body mass index (BMI) [Ratio]"/><text><reference value="#vital-3-3"/></text><statusCode code="completed"/><effectiveTime value="19310203"/><value xsi:type="PQ" value="28.2" unit="kg/m2"/></observation></component><component><observation classCode="OBS" moodCode="EVN"><templateId root="2.16.840.1.113883.10.20.22.4.27" extension="2014-06-09"/><id root="79ca4722-34c1-4fe7-a24d-c376a1612a27"/><code code="8480-6" codeSystem="2.16.840.1.113883.6.1" displayName="Systolic blood pressure"/><text><reference value="#vital-3-4"/></text><statusCode code="completed"/><effectiveTime value="19310203"/><value xsi:type="PQ" value="142" unit="mm[Hg]"/></observation></component><component><observation classCode="OBS" moodCode="EVN"><templateId root="2.16.840.1.113883.10.20.22.4.27" extension="2014-06-09"/><id root="ab5f18ad-e4ec-4b52-b8b7-773150ff5253"/><code code="8462-4" codeSystem="2.16.840.1.113883.6.1" displayName="Diastolic blood pressure"/><text><reference value="#vital-3-5"/></text><statusCode code="completed"/><effectiveTime value="19310203"/><value xsi:type="PQ" value="84" unit="mm[Hg]"/></observation></component><component><observation classCode="OBS" moodCode="EVN"><templateId root="2.16.840.1.113883.10.20.22.4.27" extension="2014-06-09"/><id root="1d592ec6-539e-4438-b222-cbf10d523847"/><code code="8867-4" codeSystem="2.16.840.1.113883.6.1" displayName="Heart rate"/><text><reference value="#vital-3-6"/></text><statusCode code="completed"/><effectiveTime value="19310203"/><value xsi:type="PQ" value="74" unit="/min"/></observation></component><component><observation classCode="OBS" moodCode="EVN"><templateId root="2.16.840.1.113883.10.20.22.4.27" extension="2014-06-09"/><id root="ff6b7d6e-94dd-410e-b019-42a18385f154"/><code code="9279-1" codeSystem="2.16.840.1.113883.6.1" displayName="Respiratory rate"/><text><reference value="#vital-3-7"/></text><statusCode code="completed"/><effectiveTime value="19310203"/><value xsi:type="PQ" value="16" unit="/min"/></observation></component><component><observation classCode="OBS" moodCode="EVN"><templateId root="2.16.840.1.113883.10.20.22.4.27" extension="2014-06-09"/><id root="861822a9-22ae-4f77-9b05-ca38adb67664"/><code code="8310-5" codeSystem="2.16.840.1.113883.6.1" displayName="Body temperature"/><text><reference value="#vital-3-8"/></text><statusCode code="completed"/><effectiveTime value="19310203"/><value xsi:type="PQ" value="36.6" unit="Cel"/></observation></component><component><observation classCode="OBS" moodCode="EVN"><templateId root="2.16.840.1.113883.10.20.22.4.27" extension="2014-06-09"/><id root="f72424c2-c927-4d11-94ca-148a308f1ac7"/><code code="59408-5" codeSystem="2.16.840.1.113883.6.1" displayName="Oxygen saturation in Arterial blood by Pulse oximetry"/><text><reference value="#vital-3-9"/></text><statusCode code="completed"/><effectiveTime value="19310203"/><value xsi:type="PQ" value="97" unit="%"/></observation></component>
    </organizer>
  </entry>
  </section>
</component>

<component>
  <section>
    <templateId root="2.16.840.1.113883.10.20.22.2.3" extension="2015-08-01"/><templateId root="2.16.840.1.113883.10.20.22.2.3.1" extension="2015-08-01"/>
    <code code="30954-2" codeSystem="2.16.840.1.113883.6.1" displayName="Relevant Diagnostic Tests and/or Laboratory Data"/>
    <title>Results</title>
    <text><table><thead><tr><th>Date</th><th>Measure</th><th>Value</th><th>Unit</th><th>Reference range</th><th>Flag</th><th>Provenance</th></tr></thead><tbody>
  <tr ID="result-26"><td>1931-02-03</td><td>Sodium [Moles/volume] in Serum or Plasma</td><td>138</td><td>mmol/L</td><td>135-145 mmol/L</td><td>Normal</td><td>S</td></tr>
  <tr ID="result-27"><td>1931-02-03</td><td>Potassium [Moles/volume] in Serum or Plasma</td><td>4.9</td><td>mmol/L</td><td>3.5-5.1 mmol/L</td><td>Normal</td><td>S</td></tr>
  <tr ID="result-28"><td>1931-02-03</td><td>Carbon dioxide, total [Moles/volume] in Serum or Plasma</td><td>22</td><td>mmol/L</td><td>Keep at 22 or above in kidney disease</td><td>Normal</td><td>S</td></tr>
  <tr ID="result-29"><td>1931-02-03</td><td>Urea nitrogen [Mass/volume] in Serum or Plasma</td><td>30</td><td>mg/dL</td><td>8-23 mg/dL</td><td>High</td><td>S</td></tr>
  <tr ID="result-30"><td>1931-02-03</td><td>Creatinine [Mass/volume] in Serum or Plasma</td><td>1.5</td><td>mg/dL</td><td>0.59-1.04 mg/dL</td><td>High</td><td>S</td></tr>
  <tr ID="result-31"><td>1931-02-03</td><td>Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI 1926)/1.73 sq M</td><td>38</td><td>mL/min/{1.73_m2}</td><td>60 or higher without other kidney damage markers; 45 to 59 is G3a, 30 to 44 is G3b, 15 to 29 is G4</td><td>Low</td><td>S</td></tr></tbody></table></text>

  <entry typeCode="DRIV">
    <organizer classCode="CLUSTER" moodCode="EVN">
      <templateId root="2.16.840.1.113883.10.20.22.4.1" extension="2015-08-01"/>
      <id root="5598dfe7-043c-47b0-b4b0-aecf6b8cd38e"/>
      <code code="51990-0" codeSystem="2.16.840.1.113883.6.1" displayName="Basic metabolic panel - Blood"/>
      <statusCode code="completed"/>
      <effectiveTime><low value="19310203"/><high value="19310203"/></effectiveTime>

      <component>
        <observation classCode="OBS" moodCode="EVN">
          <templateId root="2.16.840.1.113883.10.20.22.4.2" extension="2015-08-01"/>
          <id root="ffef0dde-43f7-478e-ad94-8a21947ac308"/>
          <code code="2951-2" codeSystem="2.16.840.1.113883.6.1" displayName="Sodium [Moles/volume] in Serum or Plasma"/>
          <text><reference value="#result-26"/></text>
          <statusCode code="completed"/>
          <effectiveTime value="19310203"/>
          <value xsi:type="PQ" value="138" unit="mmol/L"/>
          <interpretationCode code="N" codeSystem="2.16.840.1.113883.5.83" displayName="Normal"/>
          <referenceRange>
            <observationRange>
              <text>135-145 mmol/L</text>
              <value xsi:type="IVL_PQ"><low value="135" unit="mmol/L"/><high value="145" unit="mmol/L"/></value>
            </observationRange>
          </referenceRange>
        </observation>
      </component>
      <component>
        <observation classCode="OBS" moodCode="EVN">
          <templateId root="2.16.840.1.113883.10.20.22.4.2" extension="2015-08-01"/>
          <id root="48d9fa41-1615-49ab-9cb8-38c88e8c3a8a"/>
          <code code="2823-3" codeSystem="2.16.840.1.113883.6.1" displayName="Potassium [Moles/volume] in Serum or Plasma"/>
          <text><reference value="#result-27"/></text>
          <statusCode code="completed"/>
          <effectiveTime value="19310203"/>
          <value xsi:type="PQ" value="4.9" unit="mmol/L"/>
          <interpretationCode code="N" codeSystem="2.16.840.1.113883.5.83" displayName="Normal"/>
          <referenceRange>
            <observationRange>
              <text>3.5-5.1 mmol/L</text>
              <value xsi:type="IVL_PQ"><low value="3.5" unit="mmol/L"/><high value="5.1" unit="mmol/L"/></value>
            </observationRange>
          </referenceRange>
        </observation>
      </component>
      <component>
        <observation classCode="OBS" moodCode="EVN">
          <templateId root="2.16.840.1.113883.10.20.22.4.2" extension="2015-08-01"/>
          <id root="8863634c-e147-4c79-a3dd-68e9c7cd865f"/>
          <code code="2028-9" codeSystem="2.16.840.1.113883.6.1" displayName="Carbon dioxide, total [Moles/volume] in Serum or Plasma"/>
          <text><reference value="#result-28"/></text>
          <statusCode code="completed"/>
          <effectiveTime value="19310203"/>
          <value xsi:type="PQ" value="22" unit="mmol/L"/>
          <interpretationCode code="N" codeSystem="2.16.840.1.113883.5.83" displayName="Normal"/>
          <referenceRange>
            <observationRange>
              <text>Keep at 22 or above in kidney disease</text>
              <value xsi:type="IVL_PQ"><low value="22" unit="mmol/L"/><high value="29" unit="mmol/L"/></value>
            </observationRange>
          </referenceRange>
        </observation>
      </component>
      <component>
        <observation classCode="OBS" moodCode="EVN">
          <templateId root="2.16.840.1.113883.10.20.22.4.2" extension="2015-08-01"/>
          <id root="062a1512-a0ce-427b-ba1b-f79f99527010"/>
          <code code="3094-0" codeSystem="2.16.840.1.113883.6.1" displayName="Urea nitrogen [Mass/volume] in Serum or Plasma"/>
          <text><reference value="#result-29"/></text>
          <statusCode code="completed"/>
          <effectiveTime value="19310203"/>
          <value xsi:type="PQ" value="30" unit="mg/dL"/>
          <interpretationCode code="H" codeSystem="2.16.840.1.113883.5.83" displayName="High"/>
          <referenceRange>
            <observationRange>
              <text>8-23 mg/dL</text>
              <value xsi:type="IVL_PQ"><low value="8" unit="mg/dL"/><high value="23" unit="mg/dL"/></value>
            </observationRange>
          </referenceRange>
        </observation>
      </component>
      <component>
        <observation classCode="OBS" moodCode="EVN">
          <templateId root="2.16.840.1.113883.10.20.22.4.2" extension="2015-08-01"/>
          <id root="9bbd36fb-3784-4f80-a075-71248460c5ab"/>
          <code code="2160-0" codeSystem="2.16.840.1.113883.6.1" displayName="Creatinine [Mass/volume] in Serum or Plasma"/>
          <text><reference value="#result-30"/></text>
          <statusCode code="completed"/>
          <effectiveTime value="19310203"/>
          <value xsi:type="PQ" value="1.5" unit="mg/dL"/>
          <interpretationCode code="H" codeSystem="2.16.840.1.113883.5.83" displayName="High"/>
          <referenceRange>
            <observationRange>
              <text>0.59-1.04 mg/dL</text>
              <value xsi:type="IVL_PQ"><low value="0.59" unit="mg/dL"/><high value="1.04" unit="mg/dL"/></value>
            </observationRange>
          </referenceRange>
        </observation>
      </component>
    </organizer>
  </entry>
  <entry typeCode="DRIV">
    <organizer classCode="CLUSTER" moodCode="EVN">
      <templateId root="2.16.840.1.113883.10.20.22.4.1" extension="2015-08-01"/>
      <id root="a07f0847-3b21-4535-a1fa-b8116d055478"/>
      <code code="98979-8" codeSystem="2.16.840.1.113883.6.1" displayName="Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI 2021)/1.73 sq M"/>
      <statusCode code="completed"/>
      <effectiveTime><low value="19310203"/><high value="19310203"/></effectiveTime>

      <component>
        <observation classCode="OBS" moodCode="EVN">
          <templateId root="2.16.840.1.113883.10.20.22.4.2" extension="2015-08-01"/>
          <id root="bff4d4e6-cd7f-4f7a-a204-ef10f7e9c654"/>
          <code code="98979-8" codeSystem="2.16.840.1.113883.6.1" displayName="Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI 2021)/1.73 sq M"/>
          <text><reference value="#result-31"/></text>
          <statusCode code="completed"/>
          <effectiveTime value="19310203"/>
          <value xsi:type="PQ" value="38" unit="mL/min/{1.73_m2}"/>
          <interpretationCode code="L" codeSystem="2.16.840.1.113883.5.83" displayName="Low"/>
          <referenceRange>
            <observationRange>
              <text>60 or higher without other kidney damage markers; 45 to 59 is G3a, 30 to 44 is G3b, 15 to 29 is G4</text>
              <value xsi:type="IVL_PQ"><low value="60" unit="mL/min/{1.73_m2}"/></value>
            </observationRange>
          </referenceRange>
        </observation>
      </component>
    </organizer>
  </entry>
  </section>
</component>

<component>
  <section>
    <templateId root="2.16.840.1.113883.10.20.2.10" extension="2015-08-01"/>
    <code code="29545-1" codeSystem="2.16.840.1.113883.6.1" displayName="Physical findings note"/>
    <title>Physical Exam</title>
    <text><paragraph>Vital signs recorded on 1931-02-03; see the Vital Signs section. [S]</paragraph><table><thead><tr><th>System</th><th>Finding</th></tr></thead><tbody><tr><td>General</td><td>Well; blood pressure 142/84, pulse 74; weight 69.6 kg</td></tr><tr><td>Cardiovascular</td><td>Regular rhythm; no ankle swelling today</td></tr></tbody></table></text>

  </section>
</component>

<component>
  <section>
    <templateId root="2.16.840.1.113883.10.20.22.2.5" extension="2015-08-01"/><templateId root="2.16.840.1.113883.10.20.22.2.5.1" extension="2015-08-01"/>
    <code code="11450-4" codeSystem="2.16.840.1.113883.6.1" displayName="Problem List"/>
    <title>Problems</title>
    <text><table><thead><tr><th>Problem</th><th>Clinical status</th><th>Verification</th><th>Code</th><th>Provenance</th></tr></thead><tbody>
  <tr ID="problem-1">
    <td>Tiredness for some months and ankle swelling by evening, with a raised creatinine (1.42 mg/dL, race-free eGFR 40, confirmed at 38 with cystatin C) and albumin in the urine (240 mg/g) found today; cause and chronicity to be established</td><td>resolved</td><td>confirmed</td>
    <td>R94.4</td><td>S — Synthetic presenting finding, superseded by the kidney diagnosis at two weeks.</td>
  </tr>
  <tr ID="problem-2">
    <td>Elevated blood pressure at intake (164/94 mmHg, average of two readings), without a diagnosis of hypertension; home readings for one week to confirm</td><td>resolved</td><td>confirmed</td>
    <td>R03.0</td><td>S — Synthetic presenting finding, superseded by the confirmed diagnosis at two weeks.</td>
  </tr>
  <tr ID="problem-3">
    <td>Hypertension, stage 2, confirmed by home readings (average 150/88 mmHg), with chronic kidney disease</td><td>active</td><td>confirmed</td>
    <td>I12.9</td><td>S — Synthetic modern diagnosis; no blood pressure from her life is recorded.</td>
  </tr>
  <tr ID="problem-4">
    <td>Chronic kidney disease G3b A2 (eGFR 38 by creatinine and cystatin C, urine albumin-to-creatinine ratio 240 and 228 mg/g), present at least two years; small, echogenic kidneys without obstruction; most likely hypertensive kidney disease, with APOL1-associated disease possible; 5-year kidney failure risk about 7%</td><td>active</td><td>confirmed</td>
    <td>N18.32</td><td>S — Synthetic modern diagnosis linked to the kidney disease recorded at her death.</td>
  </tr>
  <tr ID="problem-5">
    <td>Anemia of chronic kidney disease, mild (hemoglobin 11.2 g/dL) with adequate iron stores; a likely part of her tiredness</td><td>active</td><td>confirmed</td>
    <td>D63.1</td><td>S — Synthetic laboratory finding.</td>
  </tr>
  <tr ID="problem-6">
    <td>Vitamin D deficiency (25-hydroxyvitamin D 17 ng/mL) with a mildly raised PTH (84 pg/mL); calcium and phosphate normal</td><td>active</td><td>confirmed</td>
    <td>E55.9</td><td>S — Synthetic laboratory finding, part of the mineral and bone check in kidney disease.</td>
  </tr></tbody></table></text>

  <entry typeCode="DRIV">
    <act classCode="ACT" moodCode="EVN">
      <templateId root="2.16.840.1.113883.10.20.22.4.3" extension="2015-08-01"/>
      <id root="ec78cb3d-0e10-4cf7-ba37-a3ebb3e7ca73"/>
      <code code="CONC" codeSystem="2.16.840.1.113883.5.6" displayName="Concern"/>
      <statusCode code="completed"/>
      <effectiveTime><low value="19310105"/><high value="19310120"/></effectiveTime>
      <entryRelationship typeCode="SUBJ">
        <observation classCode="OBS" moodCode="EVN">
          <templateId root="2.16.840.1.113883.10.20.22.4.4" extension="2015-08-01"/>
          <id root="f642ce59-cb98-4890-8bf4-629c893059f6"/>
          <code code="55607006" codeSystem="2.16.840.1.113883.6.96" displayName="Problem"/>
          <text><reference value="#problem-1"/></text>
          <statusCode code="completed"/>
          <effectiveTime><low value="19310105"/><high value="19310120"/></effectiveTime>
          <value xsi:type="CD" code="R94.4" codeSystem="2.16.840.1.113883.6.90" displayName="Abnormal results of kidney function studies"/>
        </observation>
      </entryRelationship>
    </act>
  </entry>
  <entry typeCode="DRIV">
    <act classCode="ACT" moodCode="EVN">
      <templateId root="2.16.840.1.113883.10.20.22.4.3" extension="2015-08-01"/>
      <id root="c1afe3e5-f6b8-4da6-9a17-15f309fc9482"/>
      <code code="CONC" codeSystem="2.16.840.1.113883.5.6" displayName="Concern"/>
      <statusCode code="completed"/>
      <effectiveTime><low value="19310105"/><high value="19310120"/></effectiveTime>
      <entryRelationship typeCode="SUBJ">
        <observation classCode="OBS" moodCode="EVN">
          <templateId root="2.16.840.1.113883.10.20.22.4.4" extension="2015-08-01"/>
          <id root="b7cb745d-571f-4fd6-bb77-535673c1312b"/>
          <code code="55607006" codeSystem="2.16.840.1.113883.6.96" displayName="Problem"/>
          <text><reference value="#problem-2"/></text>
          <statusCode code="completed"/>
          <effectiveTime><low value="19310105"/><high value="19310120"/></effectiveTime>
          <value xsi:type="CD" code="R03.0" codeSystem="2.16.840.1.113883.6.90" displayName="Elevated blood-pressure reading, without diagnosis of hypertension"/>
        </observation>
      </entryRelationship>
    </act>
  </entry>
  <entry typeCode="DRIV">
    <act classCode="ACT" moodCode="EVN">
      <templateId root="2.16.840.1.113883.10.20.22.4.3" extension="2015-08-01"/>
      <id root="dca765c2-27a1-4108-8244-b82633de939d"/>
      <code code="CONC" codeSystem="2.16.840.1.113883.5.6" displayName="Concern"/>
      <statusCode code="active"/>
      <effectiveTime><low value="19310120"/></effectiveTime>
      <entryRelationship typeCode="SUBJ">
        <observation classCode="OBS" moodCode="EVN">
          <templateId root="2.16.840.1.113883.10.20.22.4.4" extension="2015-08-01"/>
          <id root="fdfc6463-b918-491a-b449-2e5a49ecf232"/>
          <code code="55607006" codeSystem="2.16.840.1.113883.6.96" displayName="Problem"/>
          <text><reference value="#problem-3"/></text>
          <statusCode code="completed"/>
          <effectiveTime><low value="19310120"/></effectiveTime>
          <value xsi:type="CD" code="I12.9" codeSystem="2.16.840.1.113883.6.90" displayName="Hypertensive chronic kidney disease with stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease"/>
        </observation>
      </entryRelationship>
    </act>
  </entry>
  <entry typeCode="DRIV">
    <act classCode="ACT" moodCode="EVN">
      <templateId root="2.16.840.1.113883.10.20.22.4.3" extension="2015-08-01"/>
      <id root="220c40b1-dfc5-41d8-bbfe-f24dba2c8ac0"/>
      <code code="CONC" codeSystem="2.16.840.1.113883.5.6" displayName="Concern"/>
      <statusCode code="active"/>
      <effectiveTime><low value="19310120"/></effectiveTime>
      <entryRelationship typeCode="SUBJ">
        <observation classCode="OBS" moodCode="EVN">
          <templateId root="2.16.840.1.113883.10.20.22.4.4" extension="2015-08-01"/>
          <id root="de0fd445-8a79-4f3a-a555-03b2245bdd69"/>
          <code code="55607006" codeSystem="2.16.840.1.113883.6.96" displayName="Problem"/>
          <text><reference value="#problem-4"/></text>
          <statusCode code="completed"/>
          <effectiveTime><low value="19310120"/></effectiveTime>
          <value xsi:type="CD" code="N18.32" codeSystem="2.16.840.1.113883.6.90" displayName="Chronic kidney disease, stage 3b"/>
        </observation>
      </entryRelationship>
    </act>
  </entry>
  <entry typeCode="DRIV">
    <act classCode="ACT" moodCode="EVN">
      <templateId root="2.16.840.1.113883.10.20.22.4.3" extension="2015-08-01"/>
      <id root="fb390489-7723-4666-89a3-c4a2c6e987d2"/>
      <code code="CONC" codeSystem="2.16.840.1.113883.5.6" displayName="Concern"/>
      <statusCode code="active"/>
      <effectiveTime><low value="19310120"/></effectiveTime>
      <entryRelationship typeCode="SUBJ">
        <observation classCode="OBS" moodCode="EVN">
          <templateId root="2.16.840.1.113883.10.20.22.4.4" extension="2015-08-01"/>
          <id root="e0e50a47-8788-4a21-aa0d-0e0320ef5588"/>
          <code code="55607006" codeSystem="2.16.840.1.113883.6.96" displayName="Problem"/>
          <text><reference value="#problem-5"/></text>
          <statusCode code="completed"/>
          <effectiveTime><low value="19310120"/></effectiveTime>
          <value xsi:type="CD" code="D63.1" codeSystem="2.16.840.1.113883.6.90" displayName="Anemia in chronic kidney disease"/>
        </observation>
      </entryRelationship>
    </act>
  </entry>
  <entry typeCode="DRIV">
    <act classCode="ACT" moodCode="EVN">
      <templateId root="2.16.840.1.113883.10.20.22.4.3" extension="2015-08-01"/>
      <id root="eff91a03-7bcc-4762-919c-0baea693e178"/>
      <code code="CONC" codeSystem="2.16.840.1.113883.5.6" displayName="Concern"/>
      <statusCode code="active"/>
      <effectiveTime><low value="19310120"/></effectiveTime>
      <entryRelationship typeCode="SUBJ">
        <observation classCode="OBS" moodCode="EVN">
          <templateId root="2.16.840.1.113883.10.20.22.4.4" extension="2015-08-01"/>
          <id root="3c23e3b5-1c76-4ac6-a44d-aeb21c421a3e"/>
          <code code="55607006" codeSystem="2.16.840.1.113883.6.96" displayName="Problem"/>
          <text><reference value="#problem-6"/></text>
          <statusCode code="completed"/>
          <effectiveTime><low value="19310120"/></effectiveTime>
          <value xsi:type="CD" code="E55.9" codeSystem="2.16.840.1.113883.6.90" displayName="Vitamin D deficiency, unspecified"/>
        </observation>
      </entryRelationship>
    </act>
  </entry>
  </section>
</component>

<component>
  <section>
    <templateId root="2.16.840.1.113883.10.20.22.2.9" extension="2014-06-09"/>
    <code code="51847-2" codeSystem="2.16.840.1.113883.6.1" displayName="Evaluation + Plan note"/>
    <title>Assessment and Plan</title>
    <text><list listType="ordered"><item><content styleCode="Bold">Chronic kidney disease G3b A2 (N18.32)</content>. Potassium 4.9 mmol/L and creatinine 1.50 mg/dL (eGFR 38, from 40): the expected small rise on losartan, well under 30%. Safe to add an SGLT2 inhibitor, which KDIGO recommends with albuminuria of 200 mg/g or more. [S]<list><item>Dapagliflozin 10 mg daily, with sick-day rules.</item><item>Potassium and creatinine in four weeks.</item><item>No potassium restriction at present.</item></list></item><item><content styleCode="Bold">Hypertension with chronic kidney disease (I12.9)</content>. Improving, not at goal; dapagliflozin will lower it slightly; losartan to be increased once kidney function is stable on both. [S]<list><item>Home readings the week before the next visit.</item></list></item></list><paragraph>Protocol monitoring: items the monitoring protocol calls for at this visit. [S]</paragraph><table><thead><tr><th>Domain</th><th>Measure</th><th>Interval</th><th>Status</th><th>Detail</th></tr></thead><tbody><tr><td>Examination</td><td>Standardized office blood pressure (five minutes&apos; rest, validated cuff, average of two readings)</td><td>Every visit</td><td>Completed today</td><td>142/84</td></tr><tr><td>Self-management</td><td>Home blood pressure readings</td><td>Seven days to confirm; then the week before each visit while medicines change</td><td>Completed today</td><td>Average 140/84</td></tr><tr><td>Laboratory</td><td>Potassium, sodium, bicarbonate, urea nitrogen, creatinine and eGFR</td><td>Two to four weeks after starting or increasing an ARB or SGLT2 inhibitor; then with each eGFR check (about twice a year at G3b A2)</td><td>Completed today</td><td>Two weeks after losartan: sodium 138, potassium 4.9, bicarbonate 22 mmol/L; urea nitrogen 30, creatinine 1.50 mg/dL; eGFR 38</td></tr><tr><td>Laboratory</td><td>Urine albumin-to-creatinine ratio</td><td>Repeat to confirm; three to six months after a treatment change; then about twice a year at G3b A2</td><td>Up to date</td><td>228 mg/g two weeks ago; next three months after treatment began</td></tr><tr><td>Medication safety</td><td>Medication review: NSAIDs, contrast, dose adjustment, sick-day rules</td><td>Every visit</td><td>Completed today</td><td>No NSAIDs; acetaminophen within limits; sick-day rules for dapagliflozin added</td></tr><tr><td>Medication safety</td><td>Medicine safety: dizziness, genital infection, urine volume, sick-day rules</td><td>After starting an SGLT2 inhibitor</td><td>Completed today</td><td>Expected rise in urine volume and a small eGFR dip explained; genital hygiene advice; hold on sick days and before procedures</td></tr><tr><td>Self-management</td><td>Lifestyle: sodium below 2 g a day, activity, plant-rich diet</td><td>Every visit</td><td>Completed today</td><td>Dietitian session today: sodium below 2 g, protein about 0.8 g per kg, plant-rich meals</td></tr><tr><td>Laboratory</td><td>Hemoglobin</td><td>At least yearly at G3; recheck in three months when mildly low</td><td>Up to date</td><td>11.2 g/dL at intake; recheck in three months</td></tr><tr><td>Laboratory</td><td>Calcium, phosphate, intact PTH and 25-hydroxyvitamin D</td><td>Baseline at G3; then every 6 to 12 months; vitamin D and PTH three months after starting replacement</td><td>Up to date</td><td>Vitamin D3 started two weeks ago; recheck in three months</td></tr></tbody></table><paragraph>Goal progress:</paragraph><list><item>Blood pressure below 130/80 mmHg in the clinic and at home within two months of starting treatment, and lower if tolerated. In progress; target 1931-03-03 [S]</item><item>Urine albumin-to-creatinine ratio lower by at least 30% at the three-month check on treatment. In progress; target 1931-03-03 [S]</item><item>No NSAIDs or other avoidable kidney harms; every medicine checked against her kidney function. In progress; target 1931-03-03 [S]</item><item>An informed decision about APOL1 genetic testing, made by her after counseling. Outcome by 1931-01-20: Counseled at the consultation; she chose to defer the test and may ask for it at any time [S]</item><item>She understands her stage, her risk and the kidney replacement options, and her wishes are recorded, long before any decision is needed. In progress; target 1931-02-17 [S]</item></list><paragraph>Guideline basis: KDIGO 2024 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease (2024); KDIGO 2021 Clinical Practice Guideline for the Management of Blood Pressure in Chronic Kidney Disease (2021); Executive summary of the 2017 KDIGO Chronic Kidney Disease-Mineral and Bone Disorder (CKD-MBD) Guideline Update (2017); 2025 AHA/ACC/AANP/AAPA/ABC/ACCP/ACPM/AGS/AMA/ASPC/NMA/PCNA/SGIM Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults (2025); CMID: Clinical Monitoring Intelligence Database, chronic kidney disease, hypertension, anemia and depression monographs (2026)</paragraph><paragraph>Follow-up: Annual wellness visit in two weeks. Potassium and creatinine in four weeks. Call for dizziness, fainting, vomiting or diarrhea (hold dapagliflozin and losartan that day), or genital itching. Next scheduled visit 1931-02-17: subsequent annual wellness visit. [S]</paragraph></text>

  </section>
</component>
    </structuredBody>
  </component>
</ClinicalDocument>
